Combined Simvastatin and Irinotecan in Treating ES-SCLC Patients Relapsed From 1st Chemotherapy

NCT04985201 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Small Cell Lung Cancer

Interventions

DRUG: Irinotecan
DRUG: Simvastatin

Sponsor

Shanghai Pulmonary Hospital, Shanghai, China

Collaborators

[object Object]